Properties (56)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
gptkb:Monsanto_Company
gptkb:Covestro_AG gptkb:Pharmaceuticals_division_of_Schering_AG gptkb:Asklepios_BioPharmaceutical 2018 BlueRock Therapeutics Bayer's_acquisition_of_the_rights_to_the_drug_Vitrakvi. Bayer's_acquisition_of_the_rights_to_the_drug_Eylea. Bayer's_acquisition_of_the_rights_to_the_drug_Kovaltry. Bayer's_acquisition_of_the_rights_to_the_drug_Stivarga. Bayer's_acquisition_of_the_rights_to_the_drug_Xofigo. |
gptkbp:CEO |
gptkb:Werner_Baumann
|
gptkbp:employees |
approximately 100,000 (2020)
|
gptkbp:founded |
1863
|
gptkbp:founder |
gptkb:Friedrich_Bayer
|
gptkbp:global_presence |
operations in over 80 countries
|
gptkbp:headquarters |
gptkb:Leverkusen,_Germany
|
https://www.w3.org/2000/01/rdf-schema#label |
Bayer AG
|
gptkbp:industry |
pharmaceuticals
agricultural chemicals |
gptkbp:is_part_of |
DAX_index
|
gptkbp:market |
global market leader in consumer health products
global market leader in crop science global market leader in pharmaceuticals |
gptkbp:partnerships |
gptkb:Evotec_AG
gptkb:Ceres_Global_Ag_Corp. gptkb:CRISPR_Therapeutics gptkb:Ginkgo_Bioworks Kymab |
gptkbp:philanthropy |
gptkb:Bayer_Foundation
gptkb:Bayer_Science_&_Education_Foundation gptkb:Bayer_HealthCare_Foundation gptkb:Bayer_CropScience_Foundation gptkb:Bayer_Cares_Foundation |
gptkbp:products |
gptkb:Xarelto
Aspirin Claritin Advil |
gptkbp:research_focus |
animal health
oncology radiology women's health ophthalmology cardiovascular |
gptkbp:revenue |
approximately €43 billion (2020)
|
gptkbp:stockExchange |
gptkb:Frankfurt_Stock_Exchange
|
gptkbp:stockSymbol |
BAYN
|
gptkbp:subsidiary |
gptkb:Bayer_CropScience
gptkb:Bayer_HealthCare |
gptkbp:sustainability_initiatives |
Promote sustainable agriculture
Improve access to healthcare Carbon neutrality by 2030 Reduce greenhouse gas emissions by 30% by 2030 Increase biodiversity in agricultural practices Bayer's_Sustainability_Program |